Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024

1
EpiCast Report Clostridium Difficile Infection
(CDI) - Epidemiology Forecast to 2024
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Clostridium difficile infections (CDI) are
  primarily transmitted through the fecal-oral
  route. There are two major sources of CDI
  healthcare-associated CDI (HA-CDI) and
  community-associated CDI (CA-CDI). The typical
  clinical symptoms of CDI range from watery
  diarrhea, anorexia, and nausea, to
  hypoalbuminemia and abdominal tenderness in
  severe cases. Though suspected in all patients
  with antibiotic-associated diarrhea, the
  confirmatory diagnosis of CDI is primarily based
  on the combination of clinical features exhibited
  by the patient and the results of various
  laboratory tests including stool tests, as well
  as, in certain rare scenarios, endoscopy or
  radiologic tests. Recurrence and complications of
  CDI usually pose grave challenges for the
  treatment and management of this condition and
  occur in about 20-30 of the patients treated
  successfully for their first episode.
• This report provides an overview of the risk
  factors, comorbidities, and the global and
  historical trends for CDI in the seven major
  markets (7MM) (US, France, Germany, Italy, Spain,
  UK, and Japan). It includes a 10-year
  epidemiological forecast for the diagnosed
  incident cases of all-CDI segmented by sex and by
  age (in five-year age groups beginning at 18
  years and ending at 85 years). The term all-CDI
  is defined as any instance of suspected CDI and
  diarrhea, with stool samples testing positive for
  toxin A, B, or both (enzyme immunoassay EIA,
  cytotoxicity test, or polymerase chain reaction
  PCR) or revealing the presence of
  toxin-producing C. difficile, and includes both
  HA-CDI and CA-CDI. The report also provides the
  10-year epidemiology forecast for the all-CDI
  cases segmented by epidemiological association
  into HA-CDI and CA-CDI. Additionally, the report
  provides a 10-year epidemiological forecast for
  the recurrent all-CDI cases with a further
  segmentation by number of recurrences.
• Read More At http//www.researchbeam.com/epicast
  -report-clostridium-difficile-infection-cdi-epidem
  iology-forecast-to-2024-market

3


Table of Content
1 Table of Contents 4 1.1 List of Tables 6 1.2
List of Figures 7 2 Introduction 8 2.1 Catalyst
8 2.2 Related Reports 9 3 Epidemiology 10 3.1
Disease Background 10 3.2 Risk Factors and
Comorbidities 11 4 Appendix 48 4.1 Bibliography
48 4.2 About the Authors 55 Enquire At
http//www.researchbeam.com/epicast-report-clostri
dium-difficile-infection-cdi-epidemiology-forecast
-to-2024-market/enquire-about-report
4


Similar Market Studies
Toothbrushes Replacement Heads Market in China
to 2017 The report presents detailed data on
consumption trends in the Toothbrushes
Replacement Heads category in China, analyzing
consumption volumes and values at segment level.
It also provides indispensable data on
distribution channels along with latest industry
news and mergers acquisitions (of Oral Hygiene
market).This product is part of Canadeans new on
demand range. These reports are built on the
foundation of the most up-to-date data at the
moment of purchase, guaranteeing their
sensitivity to the current state of the market,
and facilitating informed business decisions that
can be made with the utmost of confidence.
http//www.researchbeam.com/toothbrushes-and-repl
acement-heads-in-china-to-2017-market Ewing
Sarcoma - Pipeline Review, H1 2015 Global Markets
Directs report features investigational drugs
from across globe covering over 20 therapy areas
and nearly 3,000 indications. The report is built
using data and information sourced from Global
Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. http//www.researchbeam.com/ewin
g-sarcoma-pipeline-review-h1-2015-market
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/epicast-report-clostri
dium-difficile-infection-cdi-epidemiology-forecast
-to-2024-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com